The Wistar Institute Cancer Center
Since 1972, The Wistar Institute has been a National Cancer Institute Cancer Center in basic research.
The Wistar Institute Cancer Center merges basic cancer research with translational advances toward cancer prevention, diagnosis, and therapy. The Cancer Center has a history of significant advances in cancer genetics, cancer biology, tumor immunology, and virology. Its accomplishments include:
- Identification of genes associated with breast, lung, and prostate cancer.
- Development of monoclonal antibodies used to study the pathways and proteins involved in tumor development.
- Contributions to improved cancer treatments and diagnostic tests.
Cancer Center scientists conduct research on gene expression and regulation, molecular and cellular oncogenesis, tumor microenvironment and metastasis, and translational tumor immunology. Scientists benefit from shared facilities that advance research by providing essential technical support and instrumentation and improving researchers’ efficiency. One of the great strengths of the Wistar Cancer Center is its emphasis on collaboration, both internally and with external organizations.
The Wistar Cancer Center is led by director Dario C. Altieri, M.D., who is also Wistar's president and chief executive officer.